article thumbnail

Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities

Roots Analysis

Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drug delivery strategies to the long-acting drug delivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.

article thumbnail

The Future of Drug Delivery: Exploring Large Volume Wearable Injectors

Roots Analysis

Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drug delivery. In the pursuit of creating patient-centric healthcare solutions, the medical industry has witnessed a groundbreaking advancement in drug delivery with the emergence of large volume wearable injectors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ophthalmic Drug Delivery Development – Trials and Tribulations workshop

pharmaphorum

Workshop will be on ‘Ophthalmic Drug Delivery Development – Trials and Tribulations’. Ophthalmic Drug Delivery is compelling for many reasons, including the major issue of patient compliance and tolerability of therapies. Appreciating the science and art of formulating DD products.

article thumbnail

3D-printed oral treatment for ulcerative colitis proves successful

Drug Discovery World

A first in human study of a 3D printing drug product, T21, designed to treat moderate to severe ulcerative colitis (UC), has reported positive results. Imaging results from the study confirmed that T21 tablets are precisely delivered and released to the target site (the colon) for the drug release.

article thumbnail

Autoinjector: Empowering The Healthcare Industry

Roots Analysis

In the dynamic landscape of the healthcare sector, the evolution of drug delivery systems plays a significant role in transforming the management of chronic diseases. These devices reduce injection anxiety, and are useful for patients who prefer a hands-free drug delivery experience.

article thumbnail

15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference

pharmaphorum

Sustainability for Injectable Delivery Devices. Connected Drug Delivery Devices. Hear about new technological advances in the delivery of large volume drugs. Abha Violette, Associate Director, Medical Devices and Combination Products, AstraZeneca. Primary Packaging Development.

Drugs 52
article thumbnail

14th Annual Pre-Filled Syringes and Drug Devices 2022

pharmaphorum

The Future of Drug Delivery and Combination Product Device Design. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.

Drugs 52